AQ
Aquestive Therapeutics, Inc.
AQST · NASDAQ
$4.78 +3.02% (+$0.14)
1M -0.42%
Market Cap $599.7M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$3.4
28.9% downside
Trenutna cena
$4.78
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica AQST trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 11.09x
EV/FFO N/A
P/B N/A
Growth
9 /100
Declining Rev. growth 2.24%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 144.63%
Op. margin 97.52%
FCF margin 84.95%
Quality
7 /100
Poor ROA 59.22%
Asset turnover 0.41x
ROIC 45.30%
Debt
43 /100
Moderate Int. coverage -3.79x
Current ratio 7.19x
Net debt/EBITDA N/A
Stability
27 /100
Unstable Rev. volatility 19.19%
EPS volatility 192.79%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AQST
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Daniel Barber
Employees
147
Headquarters
Warren
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report